Trial Profile
A phase I trial of GS-9722
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Mar 2018
Price :
$35
*
At a glance
- Drugs Elipovimab (Primary)
- Indications HIV infections
- Focus Adverse reactions; First in man
- 07 Mar 2018 New trial record